vs
Cable One, Inc.（CABO）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Cable One, Inc.的季度营收约是Orthofix Medical Inc.的1.7倍（$363.7M vs $219.9M），Orthofix Medical Inc.同比增速更快（2.0% vs -6.1%），Cable One, Inc.自由现金流更多（$71.6M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -5.2%）
Cable One, Inc.是美国一家宽带通信服务商，以Sparklight为品牌面向美国24个州的110万个人及商业客户提供有线电视、互联网与电话服务。该公司还拥有Fidelity Communications品牌，在阿肯色、路易斯安那、密苏里、俄克拉荷马与德克萨斯提供同类通信服务，其总部坐落于亚利桑那州凤凰城。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CABO vs OFIX — 直观对比
营收规模更大
CABO
是对方的1.7倍
$219.9M
营收增速更快
OFIX
高出8.0%
-6.1%
自由现金流更多
CABO
多$54.7M
$16.8M
两年增速更快
OFIX
近两年复合增速
-5.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $363.7M | $219.9M |
| 净利润 | — | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 25.2% | 0.2% |
| 净利率 | — | -1.0% |
| 营收同比 | -6.1% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $-0.49 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CABOOFIX
| Q4 25 | $363.7M | $219.9M | ||
| Q3 25 | $376.0M | $205.6M | ||
| Q2 25 | $381.1M | $203.1M | ||
| Q1 25 | $380.6M | $193.6M | ||
| Q4 24 | $387.2M | $215.7M | ||
| Q3 24 | $393.6M | $196.6M | ||
| Q2 24 | $394.5M | $198.6M | ||
| Q1 24 | $404.3M | $188.6M |
净利润CABOOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $86.5M | $-22.8M | ||
| Q2 25 | $-438.0M | $-14.1M | ||
| Q1 25 | $2.6M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $44.2M | $-27.4M | ||
| Q2 24 | $38.2M | $-33.4M | ||
| Q1 24 | $37.4M | $-36.0M |
毛利率CABOOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率CABOOFIX
| Q4 25 | 25.2% | 0.2% | ||
| Q3 25 | 25.2% | -8.3% | ||
| Q2 25 | -128.4% | -7.9% | ||
| Q1 25 | 25.1% | -25.2% | ||
| Q4 24 | 26.2% | -5.3% | ||
| Q3 24 | 28.0% | -9.6% | ||
| Q2 24 | 27.9% | -12.5% | ||
| Q1 24 | 29.6% | -15.6% |
净利率CABOOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | 23.0% | -11.1% | ||
| Q2 25 | -114.9% | -6.9% | ||
| Q1 25 | 0.7% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | 11.2% | -13.9% | ||
| Q2 24 | 9.7% | -16.8% | ||
| Q1 24 | 9.2% | -19.1% |
每股收益（稀释后）CABOOFIX
| Q4 25 | $-0.49 | $-0.05 | ||
| Q3 25 | $14.52 | $-0.57 | ||
| Q2 25 | $-77.70 | $-0.36 | ||
| Q1 25 | $0.46 | $-1.35 | ||
| Q4 24 | $-18.05 | $-0.76 | ||
| Q3 24 | $7.58 | $-0.71 | ||
| Q2 24 | $6.58 | $-0.88 | ||
| Q1 24 | $6.46 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $152.8M | $82.0M |
| 总债务越低越好 | $2.6B | — |
| 股东权益账面价值 | $1.4B | $450.0M |
| 总资产 | $5.6B | $850.6M |
| 负债/权益比越低杠杆越低 | 1.81× | — |
8季度趋势，按日历期对齐
现金及短期投资CABOOFIX
| Q4 25 | $152.8M | $82.0M | ||
| Q3 25 | $166.6M | $62.9M | ||
| Q2 25 | $152.9M | $65.6M | ||
| Q1 25 | $149.1M | $58.0M | ||
| Q4 24 | $153.6M | $83.2M | ||
| Q3 24 | $226.6M | $30.1M | ||
| Q2 24 | $201.5M | $26.4M | ||
| Q1 24 | $210.7M | $27.0M |
总债务CABOOFIX
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.7B | $157.2M | ||
| Q2 25 | $2.9B | $157.0M | ||
| Q1 25 | $3.0B | $156.9M | ||
| Q4 24 | $3.6B | $157.0M | ||
| Q3 24 | $3.5B | $118.5M | ||
| Q2 24 | $3.5B | $118.0M | ||
| Q1 24 | $3.6B | $118.2M |
股东权益CABOOFIX
| Q4 25 | $1.4B | $450.0M | ||
| Q3 25 | $1.4B | $442.5M | ||
| Q2 25 | $1.3B | $458.3M | ||
| Q1 25 | $1.8B | $458.3M | ||
| Q4 24 | $1.8B | $503.1M | ||
| Q3 24 | $1.9B | $525.9M | ||
| Q2 24 | $1.9B | $546.0M | ||
| Q1 24 | $1.9B | $570.3M |
总资产CABOOFIX
| Q4 25 | $5.6B | $850.6M | ||
| Q3 25 | $5.7B | $832.6M | ||
| Q2 25 | $5.8B | $837.2M | ||
| Q1 25 | $6.4B | $823.1M | ||
| Q4 24 | $6.5B | $893.3M | ||
| Q3 24 | $6.7B | $867.9M | ||
| Q2 24 | $6.7B | $882.0M | ||
| Q1 24 | $6.7B | $906.0M |
负债/权益比CABOOFIX
| Q4 25 | 1.81× | — | ||
| Q3 25 | 1.88× | 0.36× | ||
| Q2 25 | 2.16× | 0.34× | ||
| Q1 25 | 1.66× | 0.34× | ||
| Q4 24 | 1.99× | 0.31× | ||
| Q3 24 | 1.84× | 0.23× | ||
| Q2 24 | 1.87× | 0.22× | ||
| Q1 24 | 1.93× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $145.5M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $71.6M | $16.8M |
| 自由现金流率自由现金流/营收 | 19.7% | 7.6% |
| 资本支出强度资本支出/营收 | 20.3% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $278.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流CABOOFIX
| Q4 25 | $145.5M | $27.7M | ||
| Q3 25 | $156.5M | $12.4M | ||
| Q2 25 | $144.9M | $11.6M | ||
| Q1 25 | $116.3M | $-18.4M | ||
| Q4 24 | $167.6M | $23.7M | ||
| Q3 24 | $176.2M | $11.7M | ||
| Q2 24 | $155.5M | $9.0M | ||
| Q1 24 | $164.8M | $-18.6M |
自由现金流CABOOFIX
| Q4 25 | $71.6M | $16.8M | ||
| Q3 25 | $84.8M | $2.5M | ||
| Q2 25 | $76.6M | $4.5M | ||
| Q1 25 | $45.2M | $-25.1M | ||
| Q4 24 | $95.7M | $15.2M | ||
| Q3 24 | $99.2M | $6.3M | ||
| Q2 24 | $84.0M | $-360.0K | ||
| Q1 24 | $98.9M | $-29.1M |
自由现金流率CABOOFIX
| Q4 25 | 19.7% | 7.6% | ||
| Q3 25 | 22.5% | 1.2% | ||
| Q2 25 | 20.1% | 2.2% | ||
| Q1 25 | 11.9% | -13.0% | ||
| Q4 24 | 24.7% | 7.0% | ||
| Q3 24 | 25.2% | 3.2% | ||
| Q2 24 | 21.3% | -0.2% | ||
| Q1 24 | 24.5% | -15.4% |
资本支出强度CABOOFIX
| Q4 25 | 20.3% | 4.9% | ||
| Q3 25 | 19.1% | 4.8% | ||
| Q2 25 | 17.9% | 3.5% | ||
| Q1 25 | 18.7% | 3.5% | ||
| Q4 24 | 18.6% | 4.0% | ||
| Q3 24 | 19.6% | 2.7% | ||
| Q2 24 | 18.1% | 4.7% | ||
| Q1 24 | 16.3% | 5.6% |
现金转化率CABOOFIX
| Q4 25 | — | — | ||
| Q3 25 | 1.81× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 44.62× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.99× | — | ||
| Q2 24 | 4.08× | — | ||
| Q1 24 | 4.41× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CABO
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
